To identify the potential targets of SFI, SFI-treated tumor cells were subjected to transcriptomic sequencing, and based on differential expression analysis, it was found that CHOP in NSCLC may be a potential target gene of SFI. Here, DDIT3 is linked to non-small cell lung carcinoma.